There are 3131 resources available
3P - Metabolic reprogramming induced by KEAP1 mutation in NSCLC
Presenter: Renata Akhmetzianova
Session: Poster session 07
4P - CBL-B inhibition overcomes PD-1/LAG-3 mediated resistance in lung cancer
Presenter: Luisa Chocarro
Session: Poster session 07
5P - Circulating tumor cell-derived organoids from lung adenocarcinoma patients for assessment of EGFR and KRAS mutations
Presenter: Mohamed Lahmadi
Session: Poster session 07
6P - Circulating low-density neutrophils (LDNs) are associated with resistance to immunotherapy as frontline treatment for non-small cell lung cancer (NSCLC): Updated results and proteomic characterization
Presenter: Natalia Castro Unanua
Session: Poster session 07
7P - Association study between genetic variants in regulatory gene for RNA modification and prognosis in non-small cell lung cancer
Presenter: Eungbae Lee
Session: Poster session 07
8P - Profiling of zidesamtinib and other ROS1 inhibitors in an intracranial CD74-ROS1 G2032R preclinical model
Presenter: ANUPONG TANGPEERACHAIKUL
Session: Poster session 07
9P - Small-extracellular vesicles derived from NSCLC cells dampen the CD8+ T cell response against tumor
Presenter: Manon CHANG
Session: Poster session 07
10P - Multivariate analysis of functional organoid assays predicts patient responses in the clinic for colorectal and pancreatic cancer
Presenter: Anna-Rose Gryspeert
Session: Poster session 07
11P - Therapeutic effects of MRTX1133 in KRAS G12D mutant appendiceal cancer: Insights from organoid and in vivo studies
Presenter: John Paul Shen
Session: Poster session 07
12P - STING-activable pyroptotic nanoparticles deliver GSDMDNT mRNA for in situ pancreatic cancer vaccination and immunotherapy
Presenter: Shiyi Shao
Session: Poster session 07
Resources:
Abstract